CHAAN S NG to Farnesol
This is a "connection" page, showing publications CHAAN S NG has written about Farnesol.
Connection Strength
0.087
-
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors. Cancer Chemother Pharmacol. 2010 Jan; 65(2):235-41.
Score: 0.087
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.